Descriptive analysis of venous thromboembolism in Georgia trauma centers compared with national trauma centers participating in the trauma quality improvement program

The Georgia Research Institute for Trauma Study Group, Colville H. Ferdinand, Vernon Henderson

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

This study was designed to compare the incidence of venous thromboembolism (VTE) in Georgia trauma centers with other national trauma centers participating in the Trauma Quality Improvement Program (TQIP). The use of chemoprophylaxis and characteristics of patients who developed VTE were also examined. We conducted a retrospective observational study of 325,703 trauma admissions to 245 trauma centers from 2013 to 2014. Patient demographics, rate of VTE, as well as the use, type, and timing of chemoprophylaxis were compared between patients admitted to Georgia and non-Georgia trauma centers. The rate of VTE in Georgia trauma centers was 1.9 per cent compared with 2.1 per cent in other national trauma centers. Overall, 49.6 per cent of Georgia patients and 45.5 per cent of patients in other trauma centers had documented chemoprophylaxis. Low molecular weight heparin was the most commonly used medication. Most patients who developed VTE did so despite receiving prophylaxis. The rate of VTE despite prophylaxis was 3.2 per cent in Georgia and 3.1 per cent in non-Georgia trauma centers. Mortality associated with VTE was higher in Georgia trauma centers compared with national TQIP benchmarks. The incidence of VTE and use of chemoprophylaxis within Georgia trauma centers were similar to national TQIP data. Interestingly, most patients who developed VTE in both populations received VTE prophylaxis. Further research is needed to develop best-practice guidelines for prevention, early detection, and treatment in high-risk populations.

Original languageEnglish (US)
Pages (from-to)1283-1288
Number of pages6
JournalAmerican Surgeon
Volume83
Issue number11
StatePublished - Nov 1 2017

Fingerprint

Trauma Centers
Venous Thromboembolism
Quality Improvement
Wounds and Injuries
Chemoprevention
Practice Guidelines
Benchmarking
Low Molecular Weight Heparin
Incidence
Population
Observational Studies
Retrospective Studies
Demography
Mortality

ASJC Scopus subject areas

  • Surgery

Cite this

Descriptive analysis of venous thromboembolism in Georgia trauma centers compared with national trauma centers participating in the trauma quality improvement program. / The Georgia Research Institute for Trauma Study Group; Ferdinand, Colville H.; Henderson, Vernon.

In: American Surgeon, Vol. 83, No. 11, 01.11.2017, p. 1283-1288.

Research output: Contribution to journalArticle

The Georgia Research Institute for Trauma Study Group, Ferdinand, CH & Henderson, V 2017, 'Descriptive analysis of venous thromboembolism in Georgia trauma centers compared with national trauma centers participating in the trauma quality improvement program', American Surgeon, vol. 83, no. 11, pp. 1283-1288.
The Georgia Research Institute for Trauma Study Group ; Ferdinand, Colville H. ; Henderson, Vernon. / Descriptive analysis of venous thromboembolism in Georgia trauma centers compared with national trauma centers participating in the trauma quality improvement program. In: American Surgeon. 2017 ; Vol. 83, No. 11. pp. 1283-1288.
@article{7449cf663ec141f282b62af960dcbc72,
title = "Descriptive analysis of venous thromboembolism in Georgia trauma centers compared with national trauma centers participating in the trauma quality improvement program",
abstract = "This study was designed to compare the incidence of venous thromboembolism (VTE) in Georgia trauma centers with other national trauma centers participating in the Trauma Quality Improvement Program (TQIP). The use of chemoprophylaxis and characteristics of patients who developed VTE were also examined. We conducted a retrospective observational study of 325,703 trauma admissions to 245 trauma centers from 2013 to 2014. Patient demographics, rate of VTE, as well as the use, type, and timing of chemoprophylaxis were compared between patients admitted to Georgia and non-Georgia trauma centers. The rate of VTE in Georgia trauma centers was 1.9 per cent compared with 2.1 per cent in other national trauma centers. Overall, 49.6 per cent of Georgia patients and 45.5 per cent of patients in other trauma centers had documented chemoprophylaxis. Low molecular weight heparin was the most commonly used medication. Most patients who developed VTE did so despite receiving prophylaxis. The rate of VTE despite prophylaxis was 3.2 per cent in Georgia and 3.1 per cent in non-Georgia trauma centers. Mortality associated with VTE was higher in Georgia trauma centers compared with national TQIP benchmarks. The incidence of VTE and use of chemoprophylaxis within Georgia trauma centers were similar to national TQIP data. Interestingly, most patients who developed VTE in both populations received VTE prophylaxis. Further research is needed to develop best-practice guidelines for prevention, early detection, and treatment in high-risk populations.",
author = "{The Georgia Research Institute for Trauma Study Group} and Lassiter, {Randi L.} and Ashley, {Dennis W.} and Medeiros, {Regina S.} and Adam, {Bao Ling} and Nesmith, {Elizabeth G.} and Johns, {Tracy J.} and Atkins, {Elizabeth V.} and Ferdinand, {Colville H.} and Vernon Henderson and Vernon Henderson and Dayna Vidal and Amina Bhatia and Karen Hill and James Dunne and Rochella Armola and James Patterson and Jo Roland and Thomas Hawk and Kathy Sego and John Bleacher and Scott Hannay and Ashley Forsythe and Clarence McKemie and Melissa Parris and Romeo Massoud and Jeffrey Nicholas and Gina Solomon and Steven Paynter and Kim Brown and Mark Gravlee and Jim Sargent and Barry Renz and Laura Garlow and Angelina Postoev and Sabrina Westbrook and Robert Campbell and Lopez, {Le Andrea} and Kelly Mayfield and Tina Wood and Francisco Jacome and Allison Crosby and Michael Thompson and Joni Napier and John Sy and Lynnette McCall and Bruce Gioia and Gail Thornton and Dennis Spencer and Michelle Benton and Fred Mullins",
year = "2017",
month = "11",
day = "1",
language = "English (US)",
volume = "83",
pages = "1283--1288",
journal = "American Surgeon",
issn = "0003-1348",
publisher = "Southeastern Surgical Congress",
number = "11",

}

TY - JOUR

T1 - Descriptive analysis of venous thromboembolism in Georgia trauma centers compared with national trauma centers participating in the trauma quality improvement program

AU - The Georgia Research Institute for Trauma Study Group

AU - Lassiter, Randi L.

AU - Ashley, Dennis W.

AU - Medeiros, Regina S.

AU - Adam, Bao Ling

AU - Nesmith, Elizabeth G.

AU - Johns, Tracy J.

AU - Atkins, Elizabeth V.

AU - Ferdinand, Colville H.

AU - Henderson, Vernon

AU - Henderson, Vernon

AU - Vidal, Dayna

AU - Bhatia, Amina

AU - Hill, Karen

AU - Dunne, James

AU - Armola, Rochella

AU - Patterson, James

AU - Roland, Jo

AU - Hawk, Thomas

AU - Sego, Kathy

AU - Bleacher, John

AU - Hannay, Scott

AU - Forsythe, Ashley

AU - McKemie, Clarence

AU - Parris, Melissa

AU - Massoud, Romeo

AU - Nicholas, Jeffrey

AU - Solomon, Gina

AU - Paynter, Steven

AU - Brown, Kim

AU - Gravlee, Mark

AU - Sargent, Jim

AU - Renz, Barry

AU - Garlow, Laura

AU - Postoev, Angelina

AU - Westbrook, Sabrina

AU - Campbell, Robert

AU - Lopez, Le Andrea

AU - Mayfield, Kelly

AU - Wood, Tina

AU - Jacome, Francisco

AU - Crosby, Allison

AU - Thompson, Michael

AU - Napier, Joni

AU - Sy, John

AU - McCall, Lynnette

AU - Gioia, Bruce

AU - Thornton, Gail

AU - Spencer, Dennis

AU - Benton, Michelle

AU - Mullins, Fred

PY - 2017/11/1

Y1 - 2017/11/1

N2 - This study was designed to compare the incidence of venous thromboembolism (VTE) in Georgia trauma centers with other national trauma centers participating in the Trauma Quality Improvement Program (TQIP). The use of chemoprophylaxis and characteristics of patients who developed VTE were also examined. We conducted a retrospective observational study of 325,703 trauma admissions to 245 trauma centers from 2013 to 2014. Patient demographics, rate of VTE, as well as the use, type, and timing of chemoprophylaxis were compared between patients admitted to Georgia and non-Georgia trauma centers. The rate of VTE in Georgia trauma centers was 1.9 per cent compared with 2.1 per cent in other national trauma centers. Overall, 49.6 per cent of Georgia patients and 45.5 per cent of patients in other trauma centers had documented chemoprophylaxis. Low molecular weight heparin was the most commonly used medication. Most patients who developed VTE did so despite receiving prophylaxis. The rate of VTE despite prophylaxis was 3.2 per cent in Georgia and 3.1 per cent in non-Georgia trauma centers. Mortality associated with VTE was higher in Georgia trauma centers compared with national TQIP benchmarks. The incidence of VTE and use of chemoprophylaxis within Georgia trauma centers were similar to national TQIP data. Interestingly, most patients who developed VTE in both populations received VTE prophylaxis. Further research is needed to develop best-practice guidelines for prevention, early detection, and treatment in high-risk populations.

AB - This study was designed to compare the incidence of venous thromboembolism (VTE) in Georgia trauma centers with other national trauma centers participating in the Trauma Quality Improvement Program (TQIP). The use of chemoprophylaxis and characteristics of patients who developed VTE were also examined. We conducted a retrospective observational study of 325,703 trauma admissions to 245 trauma centers from 2013 to 2014. Patient demographics, rate of VTE, as well as the use, type, and timing of chemoprophylaxis were compared between patients admitted to Georgia and non-Georgia trauma centers. The rate of VTE in Georgia trauma centers was 1.9 per cent compared with 2.1 per cent in other national trauma centers. Overall, 49.6 per cent of Georgia patients and 45.5 per cent of patients in other trauma centers had documented chemoprophylaxis. Low molecular weight heparin was the most commonly used medication. Most patients who developed VTE did so despite receiving prophylaxis. The rate of VTE despite prophylaxis was 3.2 per cent in Georgia and 3.1 per cent in non-Georgia trauma centers. Mortality associated with VTE was higher in Georgia trauma centers compared with national TQIP benchmarks. The incidence of VTE and use of chemoprophylaxis within Georgia trauma centers were similar to national TQIP data. Interestingly, most patients who developed VTE in both populations received VTE prophylaxis. Further research is needed to develop best-practice guidelines for prevention, early detection, and treatment in high-risk populations.

UR - http://www.scopus.com/inward/record.url?scp=85036633299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85036633299&partnerID=8YFLogxK

M3 - Article

VL - 83

SP - 1283

EP - 1288

JO - American Surgeon

JF - American Surgeon

SN - 0003-1348

IS - 11

ER -